Nascent Biotech, Inc.
NBIO
$0.0007
-$0.0001-12.50%
OTC PK
| 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 398.95% | 116.09% | 11.65% | -15.05% | -93.48% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 159.37% | 117.39% | 145.07% | 102.62% | 83.60% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 188.21% | 116.51% | 13.34% | -13.18% | -56.96% |
|
|
|||||
| Total Current Assets | 188.21% | 116.51% | 13.34% | -13.18% | -56.96% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 188.21% | 116.51% | 13.34% | -13.18% | -56.96% |
|
|
|||||
| Total Accounts Payable | 5.99% | 37.78% | 24.92% | -33.30% | -8.32% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -78.70% | -68.56% | -73.42% | 4.06% | 326.81% |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -86.48% | -62.59% |
| Total Other Current Liabilities | -- | -- | -- | -86.48% | -62.59% |
| Total Current Liabilities | -39.88% | -47.86% | -68.35% | -56.08% | -23.83% |
|
|
|||||
| Total Current Liabilities | -39.88% | -47.86% | -68.35% | -56.08% | -23.83% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -78.70% | -68.56% | -73.42% | 4.06% | 326.81% |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -39.88% | -47.86% | -68.35% | -56.08% | -23.83% |
|
|
|||||
| Common Stock & APIC | 14.83% | 18.09% | 20.45% | 23.36% | 12.43% |
| Retained Earnings | -11.17% | -12.20% | -12.52% | -16.16% | -10.14% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 55.45% | 80.19% | 102.23% | 99.46% | 19.61% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 55.45% | 80.19% | 102.23% | 99.46% | 19.61% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 55.45% | 80.19% | 102.23% | 99.46% | 19.61% |
|
|
|||||